Published in Europace on May 14, 2015
Longevity of implantable cardioverter defibrillators: a comparison among manufacturers and over time. Europace (2015) 0.81
Longevity of biventricular defibrillators: not all devices are created equal. Europace (2015) 0.75
Economic impact of longer battery life of cardiac resynchronization therapy defibrillators in Sweden. Clinicoecon Outcomes Res (2016) 0.75
Battery drain in daily practice and medium-term projections on longevity of cardioverter-defibrillators: an analysis from a remote monitoring database. Europace (2016) 0.75
Cost-effectiveness of implantable cardioverter-defibrillators. N Engl J Med (2005) 7.46
Complication rates associated with pacemaker or implantable cardioverter-defibrillator generator replacements and upgrade procedures: results from the REPLACE registry. Circulation (2010) 2.93
Cardiac resynchronization therapy for patients with left ventricular systolic dysfunction: a systematic review. JAMA (2007) 2.93
Investigation of a novel algorithm for synchronized left-ventricular pacing and ambulatory optimization of cardiac resynchronization therapy: results of the adaptive CRT trial. Heart Rhythm (2012) 2.60
Implantable cardioverter-defibrillator longevity under clinical circumstances: an analysis according to device type, generation, and manufacturer. Heart Rhythm (2011) 1.84
Longevity of implantable cardioverter-defibrillators, influencing factors, and comparison to industry-projected longevity. Heart Rhythm (2009) 1.63
The mode of death in implantable cardioverter-defibrillator and cardiac resynchronization therapy with defibrillator patients: results from routine clinical practice. Heart Rhythm (2012) 1.55
The growing mismatch between patient longevity and the service life of implantable cardioverter-defibrillators. J Am Coll Cardiol (2005) 1.24
Long-term performance of coronary sinus leads used for cardiac resynchronization therapy. Pacing Clin Electrophysiol (2007) 1.08
Impact of extending device longevity on the long-term costs of implantable cardioverter-defibrillator therapy: a modelling study with a 15-year time horizon. Europace (2013) 1.06
Battery longevity in cardiac resynchronization therapy implantable cardioverter defibrillators. Europace (2013) 1.02
Real-world data on the lifespan of implantable cardioverter-defibrillators depending on manufacturers and the amount of ventricular pacing. J Cardiovasc Electrophysiol (2012) 1.00
Longevity of implantable cardioverter-defibrillators: implications for clinical practice and health care systems. Europace (2008) 1.00
Long-term complications related to biventricular defibrillator implantation: rate of surgical revisions and impact on survival: insights from the Italian Clinical Service Database. Circulation (2011) 0.99
Pacemakers and implantable cardioverter defibrillators: device longevity is more important than smaller size: the patient's viewpoint. Pacing Clin Electrophysiol (2004) 0.91
Automatic adjustment of stimulation output in resynchronization therapy: impact and effectiveness in clinical practice. Europace (2011) 0.83
The economic impact of battery longevity in implantable cardioverter-defibrillators for cardiac resynchronization therapy: the hospital and healthcare system perspectives. Europace (2016) 0.75
Left atrial appendage thrombi relate to easily accessible clinical parameters in patients undergoing atrial fibrillation transcatheter ablation: A multicenter study. Int J Cardiol (2017) 0.75
High-resolution mapping and ablation of recurrent left lateral accessory pathway conduction. J Arrhythm (2017) 0.75
Device Longevity in a Contemporary Cohort of ICD/CRT-D Patients Undergoing Device Replacement. J Cardiovasc Electrophysiol (2016) 0.75
Use of remote monitoring in the management of ICD end-of-life: Data from the DECODE registry. Int J Cardiol (2016) 0.75
Remote monitoring improves outcome after ICD implantation: the clinical efficacy in the management of heart failure (EFFECT) study. Europace (2015) 0.75
Cavotricuspid isthmus high-density mapping. HeartRhythm Case Rep (2016) 0.75
Association between remote implantable cardioverter defibrillator monitoring and beta-blocker utilization: An analysis from the EFFECT study. J Telemed Telecare (2015) 0.75